These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33557818)

  • 1. Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning.
    Sun C; Hong S; Song M; Li H; Wang Z
    BMC Med Inform Decis Mak; 2021 Feb; 21(1):45. PubMed ID: 33557818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A COVID-19 Pandemic Artificial Intelligence-Based System With Deep Learning Forecasting and Automatic Statistical Data Acquisition: Development and Implementation Study.
    Yu CS; Chang SS; Chang TH; Wu JL; Lin YJ; Chien HF; Chen RJ
    J Med Internet Res; 2021 May; 23(5):e27806. PubMed ID: 33900932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep representation learning from electronic medical records identifies distinct symptom based subtypes and progression patterns for COVID-19 prognosis.
    Zheng Q; Shen Q; Shu Z; Chang K; Zhong K; Yan Y; Ke J; Huang J; Su R; Xia J; Zhou X
    Int J Med Inform; 2024 Nov; 191():105555. PubMed ID: 39089210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach for COVID-19 Infection forecasting based on multi-source deep transfer learning.
    Garg S; Kumar S; Muhuri PK
    Comput Biol Med; 2022 Oct; 149():105915. PubMed ID: 36063688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of a machine learning-based in-hospital COVID-19 disease outcome predictor (CODOP): A multicontinental retrospective study.
    Klén R; Purohit D; Gómez-Huelgas R; Casas-Rojo JM; Antón-Santos JM; Núñez-Cortés JM; Lumbreras C; Ramos-Rincón JM; García Barrio N; Pedrera-Jiménez M; Lalueza Blanco A; Martin-Escalante MD; Rivas-Ruiz F; Onieva-García MÁ; Young P; Ramirez JI; Titto Omonte EE; Gross Artega R; Canales Beltrán MT; Valdez PR; Pugliese F; Castagna R; Huespe IA; Boietti B; Pollan JA; Funke N; Leiding B; Gómez-Varela D
    Elife; 2022 May; 11():. PubMed ID: 35579324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing Deep LSTMs With Later Temporal Attention for Predicting COVID-19 Severity, Clinical Outcome, and Antibody Level by Screening Serological Indicators Over Time.
    Cai J; Li Y; Liu B; Wu Z; Zhu S; Chen Q; Lei Q; Hou H; Guo Z; Jiang H; Guo S; Wang F; Huang S; Zhu S; Fan X; Tao S
    IEEE J Biomed Health Inform; 2024 Jul; 28(7):4204-4215. PubMed ID: 38564357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term SARS-CoV-2 neutralizing antibody level prediction using multimodal deep learning: A prospective cohort study on longitudinal data in Wuhan, China.
    Fang C; Yan W; Chen Y; Dou Z; Liu T; Luo F; Chen W; Li X; Chen Y; Wu W; Yuan Z; Niu Y; Wang P; Zhu W; Luo X; Chen T; Bai X; Wang X; Ning Q
    J Med Virol; 2023 Aug; 95(8):e29036. PubMed ID: 37621210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods.
    Kivrak M; Guldogan E; Colak C
    Comput Methods Programs Biomed; 2021 Apr; 201():105951. PubMed ID: 33513487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Feasibility of Multivariate Deep Learning Models in Predicting COVID-19 Epidemic.
    Chen S; Paul R; Janies D; Murphy K; Feng T; Thill JC
    Front Public Health; 2021; 9():661615. PubMed ID: 34291025
    [No Abstract]   [Full Text] [Related]  

  • 11. One-Year Lesson: Machine Learning Prediction of COVID-19 Positive Cases with Meteorological Data and Mobility Estimate in Japan.
    Rashed EA; Hirata A
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34071801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forecasting COVID-19 new cases using deep learning methods.
    Xu L; Magar R; Barati Farimani A
    Comput Biol Med; 2022 May; 144():105342. PubMed ID: 35247764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing COVID-19 Epidemic Forecasting Accuracy by Combining Real-time and Historical Data From Multiple Internet-Based Sources: Analysis of Social Media Data, Online News Articles, and Search Queries.
    Li J; Huang W; Sia CL; Chen Z; Wu T; Wang Q
    JMIR Public Health Surveill; 2022 Jun; 8(6):e35266. PubMed ID: 35507921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A composite risk model predicts disease progression in early stages of COVID-19: A propensity score-matched cohort study.
    Xu J; Gao Y; Hu S; Li S; Wang W; Wu Y; Su Z; Zhou X; Cheng X; Zheng Q
    Ann Clin Biochem; 2021 Sep; 58(5):434-444. PubMed ID: 33827266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 detection in CT and CXR images using deep learning models.
    Chouat I; Echtioui A; Khemakhem R; Zouch W; Ghorbel M; Hamida AB
    Biogerontology; 2022 Feb; 23(1):65-84. PubMed ID: 35064446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Improved STL-LSTM Model for Daily Bus Passenger Flow Prediction during the COVID-19 Pandemic.
    Jiao F; Huang L; Song R; Huang H
    Sensors (Basel); 2021 Sep; 21(17):. PubMed ID: 34502841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.